Improving primary care prescribing safety using routine data for intervention and evaluation: four trials in 500+ practices
|
|
- Gloria Farmer
- 6 years ago
- Views:
Transcription
1 University of Dundee School of Medicine Improving primary care prescribing safety using routine data for intervention and evaluation: four trials in 500+ practices
2 University of Dundee School of Medicine Improving primary care prescribing safety using routine data for intervention and evaluation: three trials and 1 interrupted time series study in 500+ practices
3 University of Dundee School of Medicine Preventable drug related harm Preventable drug-related morbidity (PRDM) is a concern o ~ 6.5% of all emergency hospital admissions are drug-related o ~ 2 to 4% are drug-related and preventable High-risk prescribing and monitoring cause 2/3 of PDRM o NSAIDs and antithrombotics: ~35% o Antihypertensives: ~30% o CNS active drugs: ~10% High-risk prescribing inappropriate or wrong prescribing o o Balance of benefit/risk Regular review necessary to ensure it continues to be appropriate
4 University of Dundee Odds ratio of patient receiving a high risk prescription in each practice School of Medicine 3.5 High-risk prescribing: Practice variation Odds ratio for each practice 3 Upper 95% CI 2.5 Lower 95% CI Practices ranked in ascending order of prevalence of high risk prescribing
5 High risk prescribing and polypharmacy No. of chronic drugs 0 drugs 1-2 drugs 3-4 drugs 5-6 drugs 7-8 drugs 9-10 drugs 11+ drugs % getting a high risk prescription Adjusted OR Four fold variation between practices Guthrie B et al. BMJ 2011;342:d3514
6 Percentage of patients receiving specified number of drugs No. of drug classes dispensed in previous 84 days in % 90% 80% 70% 60% 50% 40% 30% 20% 10% 0% drugs 1 drug 2 drugs 3 drugs 4 drugs 5 drugs 6 drugs 7 drugs 8 drugs 9 drugs 10 drugs 11 drugs 12 drugs 13 drugs 14 drugs 15+ drugs Age group Guthrie B et al. BMC Medicine 2015
7 Percentage of patients receiving specified number of drugs Percentage of patients receiving specified number of drugs 100% No. of drug classes No. of drug dispensed classes dispensed in previous in last days days in 1995 in % 90% 90% 80% 80% 70% 70% 60% 60% 50% 50% 40% 40% 30% 30% 20% 20% 10% 10% 0% 0% Age group Guthrie B et al. BMC Medicine drugs 1 drug 2 drugs 3 drugs 4 drugs 5 drugs 6 drugs 7 drugs 8 drugs 9 drugs 10 drugs 11 drugs 12 drugs 13 drugs 14 drugs 15+ drugs
8 Intervention design Which intervention components? Identify patients with high-risk prescribing from EMRs Review of patients identified Corrective action High-risk prescribing Emergency admissions
9 Intervention design Which intervention components? Behaviour change model (Michie et al)
10 Intervention design Which intervention components? Identify patients with high-risk prescribing from EMRs Review of patients identified Corrective action IT component Motivation Education High-risk prescribing Emergency admissions
11 EFIPPS
12 EFIPPS Study Design 262 practices from three Scottish health boards Study arm Randomised practices 1. Low intensity 88 practices 2. Higher intensity 87 practices 3. Highest intensity 87 practices
13 EFIPPS Intervention design Study arm 1. Low intensity 2. Higher intensity 3. Highest intensity Education Motivation IT Written education al material Written education al material Written education al material - Downloadable EMR searches to identify patients Feedback with benchmark Feedback with benchmark PLUS theory informed behaviour change intervention Downloadable EMR searches to identify patients Downloadable EMR searches to identify patients
14 EFIPPS findings
15 EFIPPS findings OR at 12 months Arm 2 vs Arm (0.80 to 0.96) Arm 3 vs Arm (0.78 to 0.95) Antipsychotics dementia 1.01/1.02 Triple whammy 0.91/0.91 NSAID aged /0.82 Antiplatelet + NSAID 0.88/0.82 OAC + NSAID 0.92/0.73 OAC + antiplatelet 0.82/0.72 Guthrie B et al BMJ 2016: i4079
16 DQIP
17 Study arm 1. Low intensity EFIPPS Intervention design Education Motivation IT Higher intensity Written educational material PLUS Educational Outreach Visit Financial incentives ( 350 participation fee plus 15 per review) IT tool - list of patients to review - facilitation of review - Run charts to monitor progress
18 DQIP Study Design 33 practices from one Scottish health board
19 DQIP findings
20 DQIP findings Primary outcome OR 0.63 (95% CI ) Ongoing high-risk prescribing OR 0.60 (95% CI ) New high-risk prescribing OR 0.77(95% CI ) Sustained 12 months after the intervention stopped GI bleeding admissions OR 0.66 (95% CI ) Heart failure admissions OR 0.73 (95% CI ) Acute kidney injury admissions OR 0.84 (95% CI ) Unrelated ACSA OR 1.02 (95% CI ) Dreischulte T et al. NEJM 2016; 374:
21 EPIPP design Cluster-randomised trial in 242 (100%) practices Both arms active Targets potentially problematic prescribing in asthma vs multiple urinary antibiotic prescribing Includes feedback of data for individual patients
22 EFIPPS Study Design 242 practices from one Scottish health board Study arm 1. Antibiotics for UTIs (control for arm 2) 2. Suboptimal prescribing for asthma (control for arm 1) Randomised practices 121 practices 121 practices
23 EPIPP Intervention design Study arm 1. Frequent use of antibiotics (control for arm 2) 2. Suboptimal asthma prescribing (control for arm 1) Education Motivation IT - - Practice level feedback - - Practice level feedback - Use of PIS to generate lists of individual patients for review - Use of PIS to generate lists of individual patients for review
24 POEMS design ITS in 54 (100%) practices Intervention is an informatics tool to support contractually incentivised polypharmacy review in people aged 75+ taking 10 or more drugs Operationalises 50+ pages of Scottish guidance 122 indicators of high-risk prescribing, potential overuse, potential underuse and monitoring failure Links data from primary care record, laboratories and unscheduled care (hospital, A&E/ER, GP out of hours)
25
26
27 Conclusion Prescribing safety is common and improvable Adds to evidence from previous trials PINCER (pharmacist led) OPTISCRIPT (GP led) All feasible in routine practice Many remaining questions Evidence is for selected indicators Apart from DQIP little data on sustainability Electronic vs paper
28 DQIP Aileen Grant, Adrian Hapca, Peter Donnan, Colin McCowan, Bruce Guthrie Health Informatics Centre EFIPPS Marion Bennie, Chris Robertson, Kim Kavanagh, Karen Barnett, Shaun Treweek, Lewis Ritchie, Dennis Petrie, Iain Bishop, Bruce Guthrie, ISD Scotland, edris EPIPP Sean Macbride-Stewart, Charis Marwick, Bruce Guthrie POEMS Jason Tang, Peter Donnan, Lyall Cameron, Graeme Longair, Neil Mellon, Grant McHattie, Bruce Guthrie
29 QUESTIONS?
30 DQIP References Dreischulte T et al. Safer prescribing: a trial of incentives, informatics and education. New England Journal of Medicine 2016: Guthrie B et al. The rising tide of polypharmacy and drug-drug interactions: population database analysis BMC Medicine 2015;13:74 Grant A et al. Developing a complex intervention to improve prescribing safety in primary care: mixed methods feasibility and optimisation pilot study. BMJ Open 2014;4:1 Guthrie B et al. High-risk prescribing in primary care patients particularly vulnerable to adverse drug events: cross-sectional population database analysis in Scottish general practice. BMJ 2011;342:d3514 EFIPPS Guthrie B et al. Data feedback and behavioural change intervention to improve primary care prescribing safety (EFIPPS): multicentre, three arm, cluster randomised controlled trial. BMJ 2016; 354: i4079 Barnett KN et al. Effective Feedback to Improve Primary Care Prescribing Safety (EFIPPS) a pragmatic three-arm-cluster randomised trial: designing the intervention. Implementation Science 2014:9(1);133
Optimising prescribing in primary care in the face of multimorbidity and polypharmacy
University of Dundee School of Medicine Optimising prescribing in primary care in the face of multimorbidity and polypharmacy Bruce Guthrie Professor of Primary Care Medicine, University of Dundee NICE
More informationNSAIDs Change Package 2017/2018
NSAIDs Change Package 2017/2018 Aim: To Reduce harm to patients from Non-Steroidal Anti-inflammatory Drugs (NSAIDs) in primary care Background A key aim of the Safety in Practice programme is to reduce
More informationTRIALS. Aileen Grant 1*, Tobias Dreischulte 2, Shaun Treweek 1 and Bruce Guthrie 1
Grant et al. Trials 2012, 13:154 TRIALS STUDY PROTOCOL Open Access Study protocol of a mixed-methods evaluation of a cluster randomized trial to improve the safety of NSAID and antiplatelet prescribing:
More informationEdinburgh Research Explorer
Edinburgh Research Explorer Effective Feedback to Improve Primary Care Prescribing Safety (EFIPPS) a pragmatic three-arm cluster randomised trial Citation for published version: Barnett, KN, Bennie, M,
More informationTackling inappropriate polypharmacy in NHS Scotland
Tackling inappropriate polypharmacy in NHS Scotland Francesca Aaen Lead Care Homes Pharmacist - NHS Lanarkshire Heather Harrison - Senior Prescribing Advisor/ Chronic Pain Primary Care Service Development
More informationNational Therapeutic Indicators and Additional Prescribing Measures 2017/18 - Early Release Document
National Therapeutic Indicators and Additional Prescribing Measures 2017/18 - Early Release Document 1 National Therapeutic Indicators 2017-18 National Therapeutic Indicators (NTIs) and Additional Prescribing
More informationOlder People with Complex Health Needs: NIHR Workshop Delegate Agenda The Royal Society 6-9 Carlton House Terrace London SW1Y 5AG
Older People with Complex Health Needs: NIHR Workshop Delegate Agenda The Royal Society 6-9 Carlton House Terrace London SW1Y 5AG Wednesday 2 nd November 2016 A workshop to identify tractable research
More informationThe OPRAA Cohort. Emma Reynish
The OPRAA Cohort Emma Reynish Chair of Dementia Research, Faculty of Social Science, University of Stirling. Consultant Geriatrician, Royal Infirmary Edinburgh, NHS Lothian Standardised Assessment of older
More informationCan Audit and Feedback Reduce Antibiotic Prescribing in Dentistry?
February 2015: RAPiD Audit and Feedback Trial Summary Can Audit and Feedback Reduce Antibiotic Prescribing in Dentistry? Antimicrobial resistance is a serious threat to global public health and patient
More informationPromoting Safer Use of High-Risk Pharmacotherapy: Impact of Pharmacist-Led Targeted Medication Reviews
Drugs - Real World Outcomes (2015) 2:261 271 DOI 10.1007/s40801-015-0031-8 ORIGINAL RESEARCH ARTICLE Promoting Safer Use of High-Risk Pharmacotherapy: Impact of Pharmacist-Led Targeted Medication Reviews
More informationTaking the harm out of Polypharmacy Step by step. Karen Reid and Claire Stein Lead Integrated Care Pharmacist NHS Lothian
Taking the harm out of Polypharmacy Step by step Karen Reid and Claire Stein Lead Integrated Care Pharmacist NHS Lothian Presentation: Polypharmacy Overview of the 2015 guidelines The Seven Steps Application
More informationPolypharmacy: Guidance for Prescribing in Frail Adults
Polypharmacy: Guidance for Prescribing in Frail Adults Why is reviewing polypharmacy important? Medication is by far the most common form of medical intervention. Four out of five people aged over 75 years
More informationThe Farr Institute Delivering new evidence and risk prediction tools through data analysis
The Farr Institute Delivering new evidence and risk prediction tools through data analysis Professor Marion Bennie, Professor of Pharmacy / Chief Pharmacist, University of Strathclyde, Gasgow / NHS National
More informationBulletin Independent prescribing information for NHS Wales
Bulletin Independent prescribing information for NHS Wales July 2016 Optimising medicines use in care homes There are currently over 22 000 resident places in older adult care homes in Wales. 1 An ageing
More informationUsing routinely collected clinical data to support Clinical Trials: a view from Scotland
Using routinely collected clinical data to support Clinical Trials: a view from Scotland Professor Colin McCowan Robertson Centre for Biostatistics and Glasgow Clinical Trials Unit From birth to death
More informationPolypharmacy. Polypharmacy. Suboptimal Prescribing in Older Adults. Kenneth Schmader, MD Professor of Medicine-Geriatrics
Polypharmacy Kenneth Schmader, MD Professor of Medicine-Geriatrics Polypharmacy Definition Causes Consequences Prevention/management Suboptimal Prescribing in Older Adults Overuse Polypharmacy Underuse
More informationThe burden of psychotropic drug prescribing in people with dementia: a population database study
Age and Ageing 2010; 39: 637 642 doi: 10.1093/ageing/afq090 Published electronically 12 July 2010 The Author 2010. Published by Oxford University Press on behalf of the British Geriatrics Society. All
More informationCover images courtesy of jk1991 at FreeDigitalPhotos.net Infographics courtesy of SIMPATHY consortium
If using any content from this document, please acknowledge the Scottish Government Polypharmacy Model of Care Group, 2018. When referencing this document, please use the following format: Scottish Government
More informationCarrying out a structured medication review
n MEDICINES OPTIMISATION Carrying out a structured medication review SHARON COANE and ROSALYNE PAYNE As part of our series on the NICE guideline on Medicines Optimisation, Sharon Coane and Rosalyne Payne
More informationThe epidemiology of polypharmacy
The epidemiology of polypharmacy Dr Rupert Payne University of Cambridge The ageing population ONS, 2010 The burden of multimorbidity Barnett K, Lancet 2012 The burden of multimorbidity Barnett K, Lancet
More informationCardiovascular polypharmacy is not associated with unplanned hospitalisation: evidence from a retrospective cohort study
Appleton et al. BMC Family Practice 2014, 15:58 RESEARCH ARTICLE Open Access Cardiovascular polypharmacy is not associated with unplanned hospitalisation: evidence from a retrospective cohort study Sarah
More informationPolypharmacy Strategy for NHS Fife
Polypharmacy Strategy for NHS Fife 2016-19 1 Introduction The purpose of this document is to describe the factors contributing to the issue of inappropriate polypharmacy as it relates to NHS Fife and proposes
More informationThe rising tide of polypharmacy and drug-drug interactions: population database analysis
Guthrie et al. BMC Medicine (2015) 13:74 DOI 10.1186/s12916-015-0322-7 RESEARCH ARTICLE Open Access The rising tide of polypharmacy and drug-drug interactions: population database analysis 1995 2010 Bruce
More informationAcknowledgements. The NTI Reference Group: Supported by:
Acknowledgements The National Therapeutic Indicators (NTIs) are developed and maintained by the Effective Prescribing and Therapeutics Branch, Scottish Government. Mr Sean MacBride-Stewart provides pharmaceutical
More informationMEDICINE OPTIMISATION IN BERKSHIRE EAST CCGS
MEDICINE OPTIMISATION IN BERKSHIRE EAST CCGS Melody Chapman, Lead CCG Prescribing Support Pharmacist 23 rd July 2015 MEDICINES OPTIMISATION TEAM Team of pharmacists who work to get the best out of medicines
More informationPresentation outline
Individualised care for older people- Polypharmacy in older people: too much, too little, trying to get the balance right Carmel M. Hughes Ph.D. School of Pharmacy Queen s University Belfast Background
More informationProcess evaluations for cluster-randomised trials of complex interventions: a proposed framework for design and reporting
Grant et al. Trials 2013, 14:15 TRIALS METHODOLOGY Open Access Process evaluations for cluster-randomised trials of complex s: a proposed framework for design and reporting Aileen Grant 1*, Shaun Treweek
More informationMedicines Optimisation Annual Report Dr Emma Harris and Neil Hardy on behalf of the Medicines Management Team June 2016
Medicines Optimisation Annual Report 2015-2016 Dr Emma Harris and Neil Hardy on behalf of the Medicines Management Team June 2016 1 Clinical Objectives Improve the effective use of medicines Maximise health
More informationSummary of funded Dementia Research Projects
Summary of funded Dementia Research Projects Health Services and Delivery Research (HS&DR) Programme: HS&DR 11/2000/05 The detection and management of pain in patients with dementia in acute care settings:
More informationRAPiD: Reducing Antibiotic Prescribing in Dentistry
RAPiD: Reducing Antibiotic Prescribing in Dentistry College of Medicine, Dentistry and Nursing Symposium 27 February 2015 Dr Paula Elouafkaoui Antibiotic Prescribing in Dentistry Antimicrobial resistance
More informationImpact and Predictors of Urinalysis Ordering Among General Medicine Patients
Impact and Predictors of Urinalysis Ordering Among General Medicine Patients Penny Yin, BHSc, MD PGY-3 Internal Medicine University of Toronto Supervisor: Dr. Jerome Leis. Canadian Society of Internal
More informationOptimising Safe & Appropriate Medicines Use and Deprescribing. Katie Smith, Director, East Anglia Medicines Information Service February 2014
Optimising Safe & Appropriate Medicines Use and Deprescribing Katie Smith, Director, East Anglia Medicines Information Service February 2014 Background Objectives How & why the OSAMU document was developed
More informationPRESCRIBING IN THE ELDERLY. CARE HOME PHARMACY TEAM Bhavini Shah, Eleesha Pentiah & Puja Vyas
PRESCRIBING IN THE ELDERLY CARE HOME PHARMACY TEAM Bhavini Shah, Eleesha Pentiah & Puja Vyas LEARNING OUTCOMES Medicines Optimisation The effects of aging on health and medicines. Polypharmacy Acute Kidney
More informationReshaping Care Pathways for Older People. Anne Hendry National Clinical Lead for Quality
Reshaping Care Pathways for Older People Anne Hendry National Clinical Lead for Quality Reshaping Care for Older People 10 Year Programme to 2021 300 million Change Fund to 2015 32 Partnerships between
More informationENSURING EXCELLENCE IN PRESCRIBING FOR OLDER ADULTS
ENSURING EXCELLENCE IN PRESCRIBING FOR OLDER ADULTS Philip J. Schneider, MS, FASHP The University of Arizona College of Pharmacy Learning Objectives: Describe the medication-use system and all interdependent
More informationGuidelines for the Management of Behavioural and Psychological Symptoms of Dementia (BPSD) Summary document for Primary Care
Guidelines for the Management of Behavioural and Psychological Symptoms of Dementia (BPSD) Summary document for Primary Care Guidelines for the Management of Behavioural and Psychological Symptoms of Dementia
More information50 years of pharmacovigilance: unfinished job
50 years of pharmacovigilance: unfinished job Joan-Ramon Laporte The role of pharmacoepidemiology in medicines regulation 108 market withdrawals in F, D & UK, 1961-93 Fulminant hepatitis Liver toxicity
More informationDeconstructing Polypharmacy. Alan B. Douglass, M.D. Director
Deconstructing Polypharmacy Alan B. Douglass, M.D. Director Recognize this patient? Mrs. Brown- 82 years young Active Medical Problems Hypertension Hyperlipidemia Type 2 Diabetes Peripheral edema Osteoarthritis
More informationPOLYPHARMACY. A practical approach to deprescribing in care homes. Care Home Pharmacy Team. Herts Valleys Clinical Commissioning Group
POLYPHARMACY A practical approach to deprescribing in care homes. Care Home Pharmacy Team Herts Valleys Clinical Commissioning Group Neeta Gulhane Specialist Pharmaceutical Advisor Care Homes The Care
More informationChoosing Wisely Long Term Care Uniquely Canadian
Choosing Wisely Long Term Care Uniquely Canadian Family Medicine Forum, Montreal November 11, 2017 Session ID S460 Room 512 ABEF Conflict of interest Dr. Fred Mather Waterloo Ontario Amgen Dr. Serge Gingras
More informationMaking Better Use of Registry Data in Designing Pragmatic Trials
Basel Institute ceb for Clinical Epidemiology and Biostatistics Making Better Use of Registry Data in Designing Pragmatic Trials Basel Biometric Society Novartis Campus, January 13, 2016 Heiner C. Bucher
More informationThink Delirium. Dr Linda Wolff Scotland
Think Delirium Dr Linda Wolff Scotland Delirium Management Pathway Scottish Delirium Association: Linda Wolff and Brian McGurn Health Improvement Scotland: Michelle Millar and Karen Goudie Outline Patrick
More informationAnticoagulatie en de oudere patiënt: Terughoudenheid gerechtvaardigd of niet?
Anticoagulatie en de oudere patiënt: Terughoudenheid gerechtvaardigd of niet? 16/06/2018 apr. Julie Hias Satellite symposium supported by the Alliance BMS/Pfizer 432BE18PR03459/ 180570 (Date of Preparation:
More informationDementia Benchmarking Indicators Definitions and Data Sources Manual
Indicators Definitions and Data Sources Manual (September 2015) 1 Contents Page Number Dementia Indicators 3 Indicator Summary Tables 4 General Notes 22 Glossary 23 Appendix 1 Dementia Criteria 24 2 Indicators
More informationHow effective are national strategies for getting evidence into practice?
How effective are national strategies for getting evidence into practice? Dr Gillian Leng Deputy Chief Executive, NICE Areas to cover Getting NICE guidance into practice Challenges National strategy Impact
More informationMEDICATIONS PRESCRIPTION AT HOSPITAL DISCHARGE IN PATIENTS WITH VALIDATED DIAGNOSIS OF DEMENTIA. Federica Edith Pisa University Hospital Udine
MEDICATIONS PRESCRIPTION AT HOSPITAL DISCHARGE IN PATIENTS WITH VALIDATED DIAGNOSIS OF DEMENTIA Federica Edith Pisa University Hospital Udine BACKGROUND Polypharmacy and psychotropic medication use are
More informationDetecting change in comparison to peers in NHS prescribing data: a novel application of cumulative sum methodology
Walker et al. BMC Medical Informatics and Decision Making (2018) 18:62 https://doi.org/10.1186/s12911-018-0642-6 RESEARCH ARTICLE Open Access Detecting change in comparison to peers in NHS prescribing
More informationCharacteristics of selective and non-selective NSAID use in Scotland
Characteristics of selective and non-selective NSAID use in Scotland Alford KMG 1, Simpson C 1, Williams D 2 1 Department of General Practice & Primary Care, The University of Aberdeen. 2 Department of
More informationThe Place for Treatments of Associated Neuropsychiatric and Other Symptoms in Alzheimer s Disease and Other Dementias
The Place for Treatments of Associated Neuropsychiatric and Other Symptoms in Alzheimer s Disease and Other Dementias The Patient and Carers Perspective Mary-Frances Morris, Trustee, Alzheimer Scotland.
More informationK Barnett, 1 C McCowan, 1 J M M Evans, 2 N D Gillespie, 3 P G Davey, 1 T Fahey 1,4. Error management
< Additional tables are published online only. To view these files please visit the journal online (http:// qualitysafety.bmj.com). 1 Division of Clinical & Population Sciences & Education, University
More informationNICE offer to STPs: CVD prevention
NICE offer to STPs: CVD prevention Zoe Girdis Regional Technical Adviser South of England and Channel Islands NICE support for STPs Based on the best available evidence of what works and is costeffective,
More informationIan Scott. Director of Internal Medicine and Clinical Epidemiology Princess Alexandra Hospital
National Workshop in Deprescribing Setting the scene Ian Scott Director of Internal Medicine and Clinical Epidemiology Princess Alexandra Hospital Associate Professor of Medicine University of Queensland
More informationDeprescribing: tackling increasing polypharmacy
CONFERENCE REPORT Deprescribing: tackling increasing polypharmacy JANET KRSKA, RACHEL HOWARD AND NINA BARNETT Deprescribing is less more? was the theme of this year s annual scientific meeting organised
More informationDavid Gardner, BSc Pharm, MSc CH&E, PharmD Professor, Department of Psychiatry & College of Pharmacy
David Gardner, BSc Pharm, MSc CH&E, PharmD Professor, Department of Psychiatry & College of Pharmacy It s no dream. Sleep well without sleeping pills. Outline Baby boomers & beyond: medication use Deprescribing
More informationMulti-morbidity in Dementia: A 21st Century Challenge. Sube Banerjee. Professor of Dementia Brighton and Sussex Medical School
Multi-morbidity in Dementia: A 21st Century Challenge Sube Banerjee Professor of Dementia Brighton and Sussex Medical School Most people of any age with any long term condition have multiple conditions
More information< = > less is more. De-diagnosing De-prescribing Non-testing
< = > less is more De-diagnosing De-prescribing Non-testing Who says? Overdiagnosis Polypharmacy False positives Too much medicine Risk aversion $$$ Sources Prof David Le Couteur, Clin Pharm and Aged Care
More informationLe politerapie complesse: l'arte del deprescribing. Andrea Corsonello IRCCS INRCA - Cosenza
Le politerapie complesse: l'arte del deprescribing Andrea Corsonello IRCCS INRCA - Cosenza Archibald Leman Cochrane (12 January 1909 18 June 1988) was a Scottish doctor noted for his book Effectiveness
More informationSafe Prescribing in Dementia
Safe Prescribing in Dementia Dr Daniel Harwood Consultant Psychiatrist and Clinical Director, London Strategic Clinical Network Gurdeep Kaur Major Rapid Access Team Senior Pharmacist, Camden CNWL NHS Trust
More informationDeprescribing: reducing inappropriate polypharmacy
MEDICINES OPTIMISATION Deprescribing: reducing inappropriate polypharmacy ANGELA DOWDEN Inappropriate prescribing and polypharmacy, particularly in elderly patients, is associated with increased risk of
More informationIntervention Study 2016 West ISD. Gillian Ritchie Clinical Pharmacist
Intervention Study 2016 West ISD Gillian Ritchie Clinical Pharmacist Introduction Annual data collection Two weeks All Medicines Management Team interventions Details recorded Classified by type Outcomes
More informationDrug use in long term care. Graziano Onder Centro Medicina Invecchiamento Università Cattolica Sacro Cuore, Rome
Drug use in long term care Graziano Onder Centro Medicina Invecchiamento Università Cattolica Sacro Cuore, Rome Polypharmacy in nursing home (USA) Concurrent use of 9 medications was reported for 39.7%
More informationSPARRA Mental Disorder: Scottish Patients at Risk of Readmission and Admission (to psychiatric hospitals or units)
SPARRA Mental Disorder: Scottish Patients at Risk of Readmission and Admission (to psychiatric hospitals or units) A report on the work to identify patients at greatest risk of readmission and admission
More informationSelecting the right patient for medication reviews
Selecting the right patient for medication reviews Prof dr Petra Denig, Clinical Pharmacy & Pharmacology, University Medical Center Groningen, the Netherlands 2 Who is in need of medication review: can
More informationPolypharmacy in the Elderly
Polypharmacy in the Elderly Or How Scotland invented the Modern World Sir William Ferguson Anderson 1914-2001 Became the first Professor of Geriatrics in the world when he was appointed to the David Cargill
More informationSMASH! The Salford Medication Safety Dashboard. Richard Williams. NIHR Greater Manchester Patient Safety Translational Research Centre
NIHR Greater Manchester Patient Safety Translational Research Centre SMASH! The Salford Medication Safety Dashboard Richard Williams This presentation summarises independent research funded by the NIHR
More informationPhysical comorbidity with bipolar disorder: lessons from UK data
Physical comorbidity with bipolar disorder: lessons from UK data Daniel Smith Symposium 33: Big data and bipolar disorder in the UK A failure of social policy and health promotion, illness prevention and
More informationReduction of High Risk Medications Using A Quality Initiative Perspective
Reduction of High Risk Medications Using A Quality Initiative Perspective Richard Mueller PharmD, MBA, MS, Director of Pharmacy Dianne Hempel BSN, RN Quality Improvement Coordinator Objectives Learn what
More informationProof of Concept: NHS Wales Atlas of Variation for Cardiovascular Disease. Produced on behalf of NHS Wales and Welsh Government
Proof of Concept: NHS Wales Atlas of Variation for Cardiovascular Disease Produced on behalf of NHS Wales and Welsh Government April 2018 Table of Contents Introduction... 3 Variation in health services...
More informationAppendix 2017UEMS031
Appendix 2017UEMS031 PREVENTION Clinical checklist This checklist should be completed for each person with dementia. Keep this chart with the person s corresponding paperwork. General symptoms Include
More informationpat hways Key therapeutic topic Published: 26 February 2016 nice.org.uk/guidance/ktt16
pat hways Anticoagulants, including non-vitamin K antagonist oral anticoagulants (NOACs) Key therapeutic topic Published: 26 February 2016 nice.org.uk/guidance/ktt16 Options for local implementation NICE
More informationAmal AL-Anazi, BSc.(Pharm) Medication Safety Officer In Eastern Region
Risks Of Polypharmacy Amal AL-Anazi, BSc.(Pharm) Medication Safety Officer In Eastern Region What is Polypharmacy? Polypharmacy means many drugs. In practice, polypharmacy refers to the use of more medication
More informationStronger together - optimizing pharmacotherapy on geriatric wards?
Stronger together - optimizing pharmacotherapy on geriatric wards? Clinicamp FOD 27/4/2018 Dr. Jean-Claude Lemper ( Geriater UZ Brussel) Apr. Julie Hias (ziekenhuisapotheker UZ Leuven) Project College
More informationDeprescribing: A Practical Guide
Deprescribing: A Practical Guide The information in this booklet should be used as a pragmatic decision aid, in conjunction with other relevant patient specific data. Useful resource links http://www.derbyshiremedicinesmanagement.nhs.uk/assets/clinical_guidelines/clinical_guidelines_fr
More informationMonitoring polypharmacy and reducing problematic prescribing
CLINICAL AUDIT Monitoring polypharmacy and reducing problematic prescribing Valid to November 2020 bpac nz better medicin e Audit Focus Patients taking ten or more medicines are at an increased risk of
More informationPolypharmacy and Deprescribing for Older People
Polypharmacy and Deprescribing for Older People Sarah Hilmer Head of Department, Clinical Pharmacology and Senior Staff Specialist Aged Care, RNSH Conjoint Professor of Geriatric Pharmacology, Sydney University
More informationA Year in Review: Novel Drug Approvals and Important FDA Safety Communications for the Year 2016
A Year in Review: Novel Drug Approvals and Important FDA Safety Communications for the Year 2016 Steven F. Nerenberg, Pharm.D. Clinical Assistant Professor Emergency Medicine Pharmacist Rutgers, The State
More informationPrimary Care Benchmarking Project. David Holland, Keele University
Primary Care Benchmarking Project David Holland, Keele University d.holland@keele.ac.uk What is the Primary Care Benchmarking Project? The new Primary Care Benchmarking Project is a tool that reports volumes
More informationNational Drug and Alcohol Treatment Waiting Times
National Drug and Alcohol Treatment Waiting Times 1 October 31 December 2017 Publication date 27 March 2018 A National Statistics publication for Scotland This is a National Statistics Publication National
More informationCommunity Based Diabetes Prevention
Community Based Diabetes Prevention Melanie Davies Professor of Diabetes Medicine Outline NIHR Programme Grant proposal and update to progress The Vascular Check programme HbA1c debate Algorithm to detect
More informationThe Urinary Tract Infection (UTI) Program for Long-Term Care
The Urinary Tract Infection (UTI) Program for Long-Term Care Jacquelyn Quirk, Evaluation Specialist, Public Health Ontario Eva Skiba, Regional IPAC Specialist, Public Health Ontario October 3, 2017 IPAC
More informationASPIRIN MISUSE AT HOME ACCORDING TO START AND STOPP IN FRAIL OLDER PERSONS
ASPIRIN MISUSE AT HOME ACCORDING TO START AND STOPP IN FRAIL OLDER PERSONS O. Dalleur 1,4, B. Boland 2,3, A. Spinewine 4-5 1 Pharmacy and 2 Geriatric Medicine, St-Luc university Hospital, 3 Institute of
More informationPrimary Outcome Results of DiRECT the Diabetes REmission Clinical Trial
Finding a practical management solution for T2DM, in primary care Primary Outcome Results of DiRECT the Diabetes REmission Clinical Trial Mike Lean, Roy Taylor, and the DiRECT Team IDF Abu Dhabi, December
More informationThe Opioid Crisis in Kentucky. Doug Oyler, PharmD Director, Office of Opioid Safety UK HealthCare
The Opioid Crisis in Kentucky Doug Oyler, PharmD Director, Office of Opioid Safety UK HealthCare Discuss the role of opioid prescribing in creating and sustaining the crisis Describe components and initiatives
More informationStudy period Total sample size (% women) 899 (37.7%) Warfarin Aspirin
Table S2 Sex- specific differences in oral anticoagulant prescription for stroke prevention in AF Total sample size (% women) Anticoagulant(s) studied Gage (2000) 1 Missouri, USA Discharged during 597
More informationAn Audit and Feedback Intervention for Reducing Antibiotic Prescribing in General Dental Practice: The RAPiD Cluster Randomised Controlled Trial
RESEARCH ARTICLE An Audit and Feedback for Reducing Antibiotic Prescribing in General Dental Practice: The RAPiD Cluster Randomised Controlled Trial a11111 OPEN ACCESS Citation: Elouafkaoui P, Young L,
More informationPolypharmacy in the Elderly: Analysis of QRESEARCH Data
Polypharmacy in the Elderly: Analysis of QRESEARCH Data Authors: Professor Julia Hippisley-Cox Professor of Clinical Epidemiology and General Practice Professor Mike Pringle Professor of General Practice
More informationapability, pportunity and otivation
apability, pportunity and otivation Coding tobacco dependence & interventions Noel Baxter GP & Commissioner Siân Williams Programme Manager On behalf of London Senate Helping Smokers Quit delivery team
More informationThe SIMPATHY economic analysis tool
The SIMPATHY economic analysis tool 1. Contents 1. Contents... 1 2. Introduction to SIMPATHY... 1 3. Introduction to the Economic Analysis Tool... 2 4. Assumptions and caveats... 3 5. How to use the tool...
More informationThe aggressiveness of cancer care near the end of life: Is it a quality of care issue?
The aggressiveness of cancer care near the end of life: Is it a quality of care issue? Craig Earle, MD MSc FRCPC Director, Health Services Research Program for Cancer Care Ontario & the Ontario Institute
More informationThe aggressiveness of cancer care near the end of life: Is it a quality of care issue?
The aggressiveness of cancer care near the end of life: Is it a quality of care issue? Craig Earle, MD MSc FRCPC Director, Health Services Research Program for Cancer Care Ontario & the Ontario Institute
More informationCARDIOVASCULAR RISK and NSAIDs
CARDIOVASCULAR RISK and NSAIDs Dr. Syed Ghulam Mogni Mowla Assistant Professor of Medicine Shaheed Suhrawardy Medical College, Dhaka INTRODUCTION NSAIDs are most commonly prescribed drugs Recent evidence
More informationThe first stop for professional medicines advice. Community Pharmacy Oral Anticoagulant Safety Audit
Community Pharmacy Oral Anticoagulant Safety Audit This audit has been developed with help and support from the following organisations: Community Pharmacy Patient Safety Group PharmOutcomes Pharmaceutical
More informationPrescribing Dilemmas. Sue Mulvenna Head of Pharmacy and CD Accountable Officer South Region SW 19 th May
Prescribing Dilemmas Sue Mulvenna Head of Pharmacy and CD Accountable Officer South Region SW 19 th May 2016 The four principles of medicines optimisation Aim to understand the patient s experience Evidence
More informationNICE guideline Published: 21 September 2016 nice.org.uk/guidance/ng56
Multimorbidity: clinical assessment and management NICE guideline Published: 21 September 2016 nice.org.uk/guidance/ng56 NICE 2018. All rights reserved. Subject to Notice of rights (https://www.nice.org.uk/terms-and-conditions#notice-ofrights).
More informationA cluster RCT of enhanced pharmacy services (EPS) to improve outcomes for patients on methadone maintenance therapy (MMT)
A cluster RCT of enhanced pharmacy services (EPS) to improve outcomes for patients on methadone maintenance therapy (MMT) M Jaffray 1, C Matheson 1, CM Bond 1, AJ Lee 1, D McLernon, 1 A Johnstone 2, L
More informationDiagnosing Cancer in Grampian An Academic GP s Perspective
Diagnosing Cancer in Grampian An Academic GP s Perspective Dr Peter Murchie Academic Primary Care, Research Group Hilton Edinburgh Carlton 6 th September 2018 A sense of perspective? Douglas Adams The
More informationTo Dip or Not To Dip. March Zoe Mason Care Home Pharmacist HCCG
To Dip or Not To Dip March 2017 Zoe Mason Care Home Pharmacist HCCG TDONTD A patient centred approach to improve the management of UTIs in Care Homes Overarching Priorities: Patient Safety, Improved Quality
More informationYellow Card Centre Scotland Centre for Adverse Reactions to Drugs (Scotland)
Yellow Card Centre Scotland Centre for Adverse Reactions to Drugs (Scotland) Minutes from Advisory Group Meeting Thursday 13 September at 2.30pm in Seminar Room 4 (FU223), Chancellor s Building, RIE Present:
More informationMedicines Optimisation the opportunities and challenges. Christina Short Medicines Optimisation Project Manager
Medicines Optimisation the opportunities and challenges Christina Short Medicines Optimisation Project Manager The remit:- Clinical Pharmacy input into the Locality Model Proposal: To contract a senior
More informationWorld Leading Expertise in Use of Medical Records
World Leading Expertise in Use of Medical Records Frank Sullivan FRSE, FRCP, FRCGP, CCFP General Medical Practitioner, North Glen Practice, Glenrothes Professor of Primary Care Medicine, University of
More information